FDA Inspection 1290376 — Janssen Pharmaceutica, N.V.

Janssen Pharmaceutica, N.V. — FEI 3002807336

The FDA completed an inspection of Janssen Pharmaceutica, N.V. on Nov 21, 2025 in Beerse. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 21, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Beerse (Belgium)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.